Fremdkapital Veränderung Datum
Akzo Nobel EUR 5.5B 743M 2026-06
Alcon AG USD 4.16B 434M 2026-03
AstraZeneca USD 26.01B 46M 2026-06
Bayer EUR 31.16B 480M 2026-06
Beiersdorf EUR 117M 15M 2025-12
DaVita Healthcare Partners USD 10.66B 150.24M 2026-06
Demant DKK 18.98B 3.71B 2025-12
E.ON EUR 36.53B 2.47B 2026-03
Essilor EUR 9.66B 190M 2026-06
Fresenius EUR 9.55B 1.24B 2026-06
Fresenius Medical Care EUR 5.82B 83.04M 2026-06
Genmab DKK 4.96B 28M 2026-06
Getinge SEK 9.09B 167M 2026-06
Givaudan CHF 4.19B 448M 2025-12
GlaxoSmithKline GBP 13.95B 65M 2026-06
GN Store Nord DKK 8.1B 790M 2026-03
GRIFOLS EUR 7.17B 1.91B 2026-06
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lonza CHF 3.88B 323M 2025-12
Merck EUR 11.21B 406M 2026-06
Novartis USD 37.49B 42M 2026-06
Philips EUR 6.32B 575M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
RWE EUR 16.43B 917M 2026-03
Sanofi EUR 14.65B 806M 2026-06
SAP EUR 8.54B 3.5B 2026-06
Smith & Nephew USD 3.21B 85M 2026-06